PONESIMOD for Multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 137 adverse event reports in the FDA FAERS database where PONESIMOD was used for Multiple sclerosis.
Most Reported Side Effects for PONESIMOD
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Product dose omission issue | 41 | 13.3% | 0 | 1 |
| Fatigue | 23 | 7.4% | 0 | 1 |
| Dizziness | 16 | 5.2% | 0 | 0 |
| Dyspnoea | 16 | 5.2% | 0 | 1 |
| Headache | 11 | 3.6% | 0 | 0 |
| Covid-19 | 10 | 3.2% | 0 | 4 |
| Drug ineffective | 9 | 2.9% | 0 | 0 |
| Hypoaesthesia | 9 | 2.9% | 0 | 1 |
| Multiple sclerosis relapse | 9 | 2.9% | 0 | 3 |
| Nausea | 9 | 2.9% | 0 | 1 |
| Pain | 8 | 2.6% | 0 | 1 |
| Somnolence | 8 | 2.6% | 0 | 1 |
| Therapy interrupted | 8 | 2.6% | 0 | 2 |
| Hypersensitivity | 7 | 2.3% | 0 | 0 |
| Multiple sclerosis | 7 | 2.3% | 0 | 3 |
Other Indications for PONESIMOD
Product used for unknown indication (132)
Relapsing-remitting multiple sclerosis (16)
Relapsing multiple sclerosis (12)
Other Drugs Used for Multiple sclerosis
DIMETHYL (78,567)
NATALIZUMAB (56,733)
INTERFERON BETA-1A (56,475)
FINGOLIMOD (43,123)
TERIFLUNOMIDE (29,963)
DALFAMPRIDINE (28,787)
GLATIRAMER (27,144)
OCRELIZUMAB (15,501)
OFATUMUMAB (11,816)
PEGINTERFERON BETA-1A (11,105)